By otakuyassine3@gmail.com 
Shares of Danaher Co. (NYSE:DHR – Get Free Report) hit a new 52-week low during mid-day trading on Thursday after Citigroup lowered their price target on the stock from $285.00 to $265.00. Citigroup currently has a buy rating on the stock. Danaher traded as low as $223.00 and last traded at $223.12, with a volume of 11405161 shares. The stock had previously closed at $247.84.
A number of other equities research analysts also recently commented on DHR. KeyCorp lifted their price target on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. Robert W. Baird dropped their price objective on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research note on Tuesday. TD Cowen raised their target price on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Guggenheim assumed coverage on shares of Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 target price for the company. Finally, StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Six equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.
Get Our Latest Research Report on DHR
Insider Activity
In other news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 11.10% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in DHR. FMR LLC raised its holdings in Danaher by 15.8% during the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after purchasing an additional 3,217,631 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Danaher by 3.0% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,097,986 shares of the conglomerate’s stock valued at $1,417,342,000 after purchasing an additional 148,251 shares in the last quarter. Fisher Asset Management LLC grew its stake in shares of Danaher by 2.6% in the 3rd quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate’s stock worth $1,265,725,000 after purchasing an additional 116,299 shares during the last quarter. Massachusetts Financial Services Co. MA raised its holdings in shares of Danaher by 17.6% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock worth $996,141,000 after purchasing an additional 535,254 shares in the last quarter. Finally, Montrusco Bolton Investments Inc. boosted its holdings in Danaher by 0.6% during the fourth quarter. Montrusco Bolton Investments Inc. now owns 1,715,826 shares of the conglomerate’s stock worth $382,936,000 after buying an additional 9,942 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Danaher Stock Performance
The company’s 50-day simple moving average is $235.66 and its 200-day simple moving average is $253.24. The stock has a market cap of $160.75 billion, a price-to-earnings ratio of 42.15, a price-to-earnings-growth ratio of 4.22 and a beta of 0.83. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.72%. During the same quarter last year, the firm earned $2.09 earnings per share. Analysts predict that Danaher Co. will post 8.15 EPS for the current fiscal year.
Danaher Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.49%. The ex-dividend date was Friday, December 27th. Danaher’s dividend payout ratio is currently 20.45%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Recommended Stories
Receive News & Ratings for Danaher Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Danaher and related companies with MarketBeat.com’s FREE daily email newsletter.